A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes
NCT ID: NCT06802198
Last Updated: 2025-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
500 participants
INTERVENTIONAL
2025-10-01
2030-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will fill the following questionnaires pre-operatively and at the follow up:
* Short Form 36 (SF36),
* Euro Quality of life 5D-3L (EQ 5D-3L)
* Female Sexual Function Index (FSFI)
* Patient Global Impression of Improvement (PGI-I) only during the follow-up period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy
NCT01289314
Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy
NCT05421156
Laparoscopic Supracervical Hysterectomy Versus Total Laparoscopic Hysterectomy
NCT00734812
Effect of Salpingectomy During Conservative Hysterectomy
NCT01628432
Feasibility of a Trial of Laparoscopic Hysterectomy Versus Laparoscopic Sub-Total Hysterectomy
NCT01825915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients undergoing total hysterectomy
Total hysterectomy involves the complete removal of the uterus including the cervix
total hysterectomy
Total hysterectomy (TH) involves the complete removal of the uterus including the cervix
patients undergoing subtotal hysterectomy
Subtotal hysterectomy involves the removal of the upper part of the uterus preserving the cervix
subtotal hysterectomy
subtotal hysterectomy (STH) preserves the cervix while removing the upper part of the uterus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
total hysterectomy
Total hysterectomy (TH) involves the complete removal of the uterus including the cervix
subtotal hysterectomy
subtotal hysterectomy (STH) preserves the cervix while removing the upper part of the uterus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent
Exclusion Criteria
* Abnormal or unknown PAP test
* Patients with invasive neoplasia in the previous 5 years (excluding non-melanoma skin tumors, breast cancer T1 N0 M0 Grade 1 or 2 without signs of recurrence or activity).
* Previous radical pelvic surgery or radiotherapy;
* Age \> 80 years
* Pregnant patients
* Desire for further pregnancies
* Contraindications to general anaesthesia or to the Trendelenburg position
* Refusal to sign informed consent
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni Panico, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Ginecologia Oncologica
Rome, Lazio, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6429
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.